DSCI Share Price

Open 4.70 Change Price %
High 4.70 1 Day -0.25 -5.26
Low 4.50 1 Week -0.10 -2.17
Close 4.50 1 Month -0.05 -1.10
Volume 26076 1 Year -0.02 -0.44
52 Week High 5.86
52 Week Low 0.00
DSCI Important Levels
Resistance 2 4.69
Resistance 1 4.61
Pivot 4.57
Support 1 4.39
Support 2 4.31
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

Derma Sciences, Inc. (NASDAQ: DSCI)

DSCI Technical Analysis 1.5
As on 2nd Dec 2016 DSCI Share Price closed @ 4.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.06 & Sell for SHORT-TERM with Stoploss of 4.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
DSCI Target for December
1st Target up-side 5.24
2nd Target up-side 5.54
3rd Target up-side 5.85
1st Target down-side 4.36
2nd Target down-side 4.06
3rd Target down-side 3.75
DSCI Other Details
Segment EQ
Market Capital 147873264.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.dermasciences.com
DSCI Address
DSCI
214 Carnegie Center
Suite 300
Princeton, NJ 08540
United States
Phone: 609-514-4744
Fax: 609-514-8554
DSCI Latest News
Interactive Technical Analysis Chart Derma Sciences, Inc. ( DSCI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Derma Sciences, Inc.
DSCI Business Profile
Derma Sciences, Inc. (Derma Sciences), is a medical technology company focused on three segments of the wound care marketplace: pharmaceutical wound care, advanced wound care and traditional wound care products. pharmaceutical wound care, advanced specialty medical device/pharmaceutical company with a primary focus on wound care. The Company has one pharmaceutical wound care product candidate that has completed a Phase 2 study and is working towards initiation of a Phase 3 study in 2012. The majority of its products are sold through distributors to various health care providers such as wound care centers, extended care facilities, acute care facilities, home health care agencies and physicians´┐Ż offices. Some of its products are sold through retail channels. Effective September 4, 2013, Derma Sciences Inc acquired a 7.3% stake in Comvita Ltd, a manufacturer and wholesaler of natural health products.